Lupus & antiphospholipid syndrome
Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort
Authors' conclusion
Traditional risk factors rather than lupus disease process or IS influenced the risk of COVID-19 in our cohort.
Study context
- Population
- Patients with SLE across 15 rheumatology centres during the first wave of the pandemic (April-December 2020)
- Participants
- 1,379 patients
- Exposure
- Risk factors in COVID-19 positive vs negative SLE patients
- COVID-19 positiven = 36
- Outcome
- COVID-19 and its risk factors
- Follow-up
- 6 months
Methodological detailslongitudinal, multicentre (15 rheumatology centres), adjusted analysis
- Longitudinal
- Multicentre (15 rheumatology centres)
- Adjusted analysis
Main finding
As reported in the abstract
April-December 2020
Adjusted relative risk (95% CI)
Male gender
3.72(1.85,7.51)
Diabetes
2.94(1.28–6.79)
- SLE patients who developed COVID-19
- 36/1379 (2.9%)
Observational data: associations, not effects.
Further findings
- Death due to COVID-19 — COVID-19 positive
- 1/36
Original publication
Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort. Lupus. Published 2 February 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →